Company Filing History:
Years Active: 2008-2010
Title: Elio F Vanin: Innovator in Gene Delivery Systems
Introduction
Elio F Vanin is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of gene delivery, particularly through his work on adeno-associated viral (AAV) vectors. With a total of 2 patents, Vanin's innovations are paving the way for advancements in gene therapy.
Latest Patents
One of Vanin's latest patents focuses on tetracycline-regulated adeno-associated viral (AAV) vectors for gene delivery to the nervous system. This patent describes a vector and a method for delivering a nucleic acid to a nervous system cell. The vector comprises a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system. This system includes a first promoter operably linked to the first nucleic acid and a second promoter operably linked to the second nucleic acid. The promoters drive expression in opposite directions and away from the inverted terminal repeats. The method involves providing a recombinant adeno-associated viral (rAAV) vector and administering it to a nervous system cell. The expression of a product from the first nucleic acid is regulatable by the promoter system.
Career Highlights
Elio F Vanin is affiliated with Children's Memorial Hospital, where he continues to advance research in gene therapy. His work has been instrumental in developing innovative methods for gene delivery, which have the potential to transform treatment options for various neurological conditions.
Collaborations
Vanin has collaborated with notable colleagues, including Martha C Bohn and Lixin Jiang. These partnerships have fostered a collaborative environment that enhances the research and development of gene delivery systems.
Conclusion
Elio F Vanin's contributions to the field of gene delivery through his innovative patents and collaborations highlight his role as a key figure in advancing medical research. His work continues to inspire future developments in gene therapy.